Published in J Gen Intern Med on January 11, 2011
Insights into Chinese perspectives on do-not-resuscitate (DNR) orders from an examination of DNR order form completeness for cancer patients. Support Care Cancer (2013) 1.09
Variation in do-not-resuscitate orders for patients with ischemic stroke: implications for national hospital comparisons. Stroke (2014) 0.90
Use of a standardized code status explanation by residents among hospitalized patients. J Community Hosp Intern Med Perspect (2014) 0.80
Do-not-resuscitate orders among advanced-stage Chinese lung cancer patients who died in hospital. Support Care Cancer (2015) 0.78
Experiences of Iranian physicians regarding do not resuscitate: a directed-content analysis. J Med Ethics Hist Med (2016) 0.77
Conversations about treatment at the end of life. J Gen Intern Med (2011) 0.75
The Natural History of Changes in Preferences for Life-Sustaining Treatments and Implications for Inpatient Mortality in Younger and Older Hospitalized Adults. J Am Geriatr Soc (2016) 0.75
Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA (2008) 11.32
The influence of the probability of survival on patients' preferences regarding cardiopulmonary resuscitation. N Engl J Med (1994) 6.39
Redefining the "planning" in advance care planning: preparing for end-of-life decision making. Ann Intern Med (2010) 4.60
Patient preferences for communication with physicians about end-of-life decisions. SUPPORT Investigators. Study to Understand Prognoses and Preference for Outcomes and Risks of Treatment. Ann Intern Med (1997) 4.56
Opening the black box: how do physicians communicate about advance directives? Ann Intern Med (1998) 3.98
Recommendations for end-of-life care in the intensive care unit: a consensus statement by the American College [corrected] of Critical Care Medicine. Crit Care Med (2008) 3.85
A national survey of end-of-life care for critically ill patients. Am J Respir Crit Care Med (1998) 3.48
Prognostication during physician-family discussions about limiting life support in intensive care units. Crit Care Med (2007) 2.96
Practical guidance for evidence-based ICU family conferences. Chest (2008) 2.68
End-of-life care for the critically ill: A national intensive care unit survey. Crit Care Med (2006) 2.61
Toward shared decision making at the end of life in intensive care units: opportunities for improvement. Arch Intern Med (2007) 2.56
Are physicians' recommendations to limit life support beneficial or burdensome? Bringing empirical data to the debate. Am J Respir Crit Care Med (2009) 2.46
How do medical residents discuss resuscitation with patients? J Gen Intern Med (1995) 2.20
Communication and decision-making in seriously ill patients: findings of the SUPPORT project. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc (2000) 2.12
Do-not-resuscitate order after 25 years. Crit Care Med (2003) 2.05
A controlled trial of a short course to improve residents' communication with patients at the end of life. Acad Med (2006) 1.88
Patient knowledge and physician predictions of treatment preferences after discussion of advance directives. J Gen Intern Med (1998) 1.74
Surrogates' predictions of seriously ill patients' resuscitation preferences. Arch Fam Med (1995) 1.70
Effect of decisions to withhold life support on prolonged survival. Chest (2008) 1.64
Dying cancer patients talk about euthanasia. Soc Sci Med (2008) 1.59
Understanding cardiopulmonary resuscitation decision making: perspectives of seriously ill hospitalized patients and family members. Chest (2006) 1.53
The language of prognostication in intensive care units. Med Decis Making (2008) 1.29
Decisions to forgo life-sustaining therapy in ICU patients independently predict hospital death. Intensive Care Med (2003) 1.25
How qualitative research can contribute to research in the intensive care unit. J Crit Care (2007) 1.19
Empathy and life support decisions in intensive care units. J Gen Intern Med (2008) 1.18
Discussing prognosis with patients and their families near the end of life: impact on satisfaction with end-of-life care. Open Med (2009) 1.17
Resident approaches to advance care planning on the day of hospital admission. Arch Intern Med (2006) 1.13
A prospective study of patient-physician communication about resuscitation. J Am Geriatr Soc (2000) 0.99
Improving medical student intensive care unit communication skills: a novel educational initiative using standardized family members. Crit Care Med (2006) 0.99
What should we say when discussing "code status" and life support with a patient? A Delphi analysis. J Palliat Med (2010) 0.96
The implications of dying cancer patients' talk on cardiopulmonary resuscitation and do-not-resuscitate orders. Qual Health Res (2007) 0.94
End-of-life care: what do the American courts say? Crit Care Med (2001) 0.92
The perceptions of do-not-resuscitate policies of dying patients with cancer. Psychooncology (2008) 0.88
Assisted suicide, depression, and the right to die. Psychol Public Policy Law (2000) 0.82
Wide variation in content of inpatient do-not-resuscitate order forms used at National Cancer Institute-designated cancer centers in the United States. Support Care Cancer (2008) 0.78
Is euthanasia compatible with palliative care? Singapore Med J (1999) 0.77
Residents talk about end-of-life issues. J Long Term Care Adm (1994) 0.77
Variables associated with medication errors in pediatric emergency medicine. Pediatrics (2002) 2.86
Development of a triage protocol for critical care during an influenza pandemic. CMAJ (2006) 2.78
Seeking worldwide professional consensus on the principles of end-of-life care for the critically ill. The Consensus for Worldwide End-of-Life Practice for Patients in Intensive Care Units (WELPICUS) study. Am J Respir Crit Care Med (2014) 2.46
IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia. Am J Hematol (2010) 2.35
Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study. Blood (2014) 2.01
ICU management of severe acute respiratory syndrome. Intensive Care Med (2003) 1.81
Salvage second hematopoietic cell transplantation in myeloma. Biol Blood Marrow Transplant (2013) 1.80
An observational study of outcomes after initial infused therapy in Medicare patients diagnosed with chronic lymphocytic leukemia. Blood (2010) 1.67
Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura. Am J Hematol (2009) 1.58
Using standardized family members to teach communication skills and ethical principles to critical care trainees. Crit Care Med (2012) 1.52
The rules of the game: interprofessional collaboration on the intensive care unit team. Crit Care (2004) 1.48
Perceptions of "futile care" among caregivers in intensive care units. CMAJ (2007) 1.48
On pandemics and the duty to care: whose duty? who cares? BMC Med Ethics (2006) 1.43
Conflicts in the ICU: perspectives of administrators and clinicians. Intensive Care Med (2009) 1.40
Challenging beliefs and ethical concepts: the collateral damage of SARS. Crit Care (2003) 1.30
Phase I-II trial of bortezomib plus oral cyclophosphamide and prednisone in relapsed and refractory multiple myeloma. J Clin Oncol (2008) 1.23
Clinical trials and novel pathogens: lessons learned from SARS. Emerg Infect Dis (2004) 1.14
Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma. Blood (2011) 1.12
Second autologous stem cell transplantation as salvage therapy for multiple myeloma: impact on progression-free and overall survival. Biol Blood Marrow Transplant (2011) 1.10
Smoldering multiple myeloma requiring treatment: time for a new definition? Blood (2013) 1.09
Large errors in the dosing of medications for children. N Engl J Med (2002) 1.06
Trends and outcomes of modern staging of solitary plasmacytoma of bone. Am J Hematol (2012) 1.01
Ethical framework for resource allocation during a drug supply shortage. Healthc Q (2012) 0.99
Clinical outcomes in t(4;14) multiple myeloma: a chemotherapy-sensitive disease characterized by rapid relapse and alkylating agent resistance. J Clin Oncol (2005) 0.99
What should we say when discussing "code status" and life support with a patient? A Delphi analysis. J Palliat Med (2010) 0.96
Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma. Cancer (2012) 0.96
An interactive educational workshop to improve end of life communication skills. J Contin Educ Health Prof (2008) 0.93
Weekly cyclophosphamide and alternate-day prednisone: an effective, convenient, and well-tolerated oral treatment for relapsed multiple myeloma after autologous stem cell transplantation. Mayo Clin Proc (2005) 0.91
Best interests at end of life: an updated review of decisions made by the Consent and Capacity Board of Ontario. J Crit Care (2013) 0.91
Impact on health care workers employed in high-risk areas during the Toronto SARS outbreak. J Psychosom Res (2008) 0.88
Age 40 years and under does not confer superior prognosis in patients with multiple myeloma undergoing upfront autologous stem cell transmplant. Biol Blood Marrow Transplant (2009) 0.87
A review of immune thrombocytopenic purpura: focus on the novel thrombopoietin agonists. J Blood Med (2010) 0.79
Pro/con ethics debate: is nonheart-beating organ donation ethically acceptable? Crit Care (2002) 0.78
Impact of race and ethnicity on outcomes and health care utilization after allogeneic hematopoietic cell transplantation. Leuk Lymphoma (2014) 0.78
Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-Medicare. J Cancer Epidemiol (2012) 0.78
Conflicts of interest, authorship, and disclosures in industry-related scientific publications. Mayo Clin Proc (2010) 0.75
Standard of care and resource implications of the Cuthbertson v. Rasouli ruling. CMAJ (2014) 0.75
Estimating the Population Benefits and Costs of Rituximab Therapy in the United States from 1998 to 2013 Using Real-World Data. Med Care (2016) 0.75
Same-Day Consent for Regional Anesthesia Clinical Research Trials: It's About Time. Anesth Analg (2020) 0.75
The blue man: a novel cutaneous manifestation of systemic amyloidosis. Amyloid (2011) 0.75
Stopping the Resuscitation When Family Is Present: Teaching Ethical and Professional Challenges. Simul Healthc (2017) 0.75
Resident preparedness in discussing prognosis in patients with advanced lung cancer. Support Care Cancer (2009) 0.75
Ethics and critical care in the new millennium. Crit Care (2002) 0.75
Chronic Anemia and the Role of the Infusion Therapy Nurse. J Infus Nurs (2015) 0.75
Cultural and religious aspects of care in the intensive care unit within the context of patient-centred care. Healthc Q (2007) 0.75